Trogenix Further Strengthens its Scientific Advisory Board with the Appointment of World-Leading Experts, Prof Nada Jabado and Prof Burkhard Becher ...

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity ...

Currently, PH is primarily diagnosed through right heart catheterization (RHC), an invasive and resource-intensive procedure. Transthoracic echocardiography (TTE), while commonly used as a screening ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial service to pharma companies, was ...

A live webcast of the presentation can be accessed under “ News and Events ” on the Investor Relations section of the Mineralys website at www.mineralystx.com. A replay of the presentation will be ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

To register for one-on-one meetings with management in New York City, interested parties should contact John Perez at [email protected].

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the opening of a new BVA program at a premier Florida healthcare center in the Tampa Bay ...

Sack the Stigma’s Mental Health Playbook’s Campaign features collegiate athletes sharing practical strategies and personal stories covering a range of mental wellness topics, including stress ...

Avance Clinical, the award-winning, global CRO for biotechs, is proud to announce its sponsorship of the Citeline Awards 2025, to be held in Boston tomorrow, May 8, 2025. Recognized as a premier ...

While analyzing the customer reviews of PrimeBiome, we primarily focused on whether customers have any major complaints ...

Randomised trial, 20-week treatment protocol plus 6-month follow up ...